MedTrace Logo

Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients

NCT02615197 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2019-09-17

No results posted yet for this study

Summary

The present project has two primary aims: (1) to examine the effectiveness of a multi-component implementation strategy in improving adoption and adherence to the Dialectical Behavior Therapy Prolonged Exposure (DBT PE) protocol, and (2) to evaluate the feasibility, acceptability, and effectiveness of the DBT PE protocol in a sample of individuals receiving DBT in public mental health agencies. This study uses a hybrid type 2 effectiveness-implementation design to simultaneously test the clinical effectiveness of DBT + DBT PE and to evaluate an adaptive, multi-component implementation strategy. The effectiveness trial will use a quasi-experimental, controlled design to evaluate outcomes among DBT clients with PTSD who do versus do not receive the DBT PE protocol and outcomes will be benchmarked to those obtained in research settings.

Conditions

  • Post-traumatic Stress Disorder
  • Suicide
  • Self-injurious Behavior

Interventions

BEHAVIORAL

Dialectical Behavior Therapy

Includes all components of standard DBT (individual therapy, group skills training, phone coaching, and therapist consultation team).

BEHAVIORAL

Dialectical Behavior Therapy Prolonged Exposure protocol

Includes an adapted version of Prolonged Exposure therapy for PTSD.

Sponsors & Collaborators

Principal Investigators

  • Melanie S Harned, PhD · University of Washington

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02615197 on ClinicalTrials.gov